Medtronic (NYSE: MDT) and Integer (NYSE:ITGR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations.

Earnings and Valuation

This table compares Medtronic and Integer’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Medtronic $29.71 billion 3.64 $4.03 billion $3.65 21.88
Integer $1.39 billion 1.06 $5.96 million $0.63 73.57

Medtronic has higher revenue and earnings than Integer. Medtronic is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Medtronic and Integer, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medtronic 0 10 12 0 2.55
Integer 0 3 1 0 2.25

Medtronic currently has a consensus price target of $88.16, suggesting a potential upside of 10.38%. Integer has a consensus price target of $51.00, suggesting a potential upside of 10.03%. Given Medtronic’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Medtronic is more favorable than Integer.

Institutional & Insider Ownership

81.9% of Medtronic shares are owned by institutional investors. Comparatively, 95.1% of Integer shares are owned by institutional investors. 0.3% of Medtronic shares are owned by insiders. Comparatively, 4.8% of Integer shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

Medtronic has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, Integer has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500.


This table compares Medtronic and Integer’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Medtronic 16.93% 12.63% 6.51%
Integer 1.42% 11.22% 3.03%


Medtronic pays an annual dividend of $1.84 per share and has a dividend yield of 2.3%. Integer does not pay a dividend. Medtronic pays out 50.4% of its earnings in the form of a dividend. Integer has raised its dividend for 39 consecutive years.


Medtronic beats Integer on 11 of the 17 factors compared between the two stocks.

About Medtronic

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company’s subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

About Integer

Greatbatch, Inc. is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise. Greatbatch Medical’s products include medical devices and components for the cardiac, neuromodulation, orthopedics, portable medical, vascular and energy markets. QiG focuses on developing medical device systems for some of healthcare’s challenges and reflects the Company’s strategic evolution of its product offerings in order to raise the growth and profitability profile of the Company. QiG utilizes a diversified portfolio approach with three investment modes: new medical device systems commercialization, collaborative programs with OEM customers and strategic equity positions in emerging healthcare companies.

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with's FREE daily email newsletter.